CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Acceleron Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 12, 2024Methods And Compositions For Treating Myelofibrosis2
Mar 27, 2024Methods For Treating Myelodysplastic Syndromes And Sideroblastic Anemias1
Dec 20, 2023Methods For Treating Eye Disorders1

Top competitors of Acceleron Pharma

List of top competitors of Acceleron Pharma based on patent oppositions.